We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.

For more information visit our privacy policy.

PD&E Study Sample Clauses

PD&E Study. The PD&E Study, which was completed by the Developer and approved by the County, FDOT and FHA, establishes the alignment of S.R. 56 from Xxxxxx Chapel Lakes Boulevard (west of the MPUD) east to U.S. 301 (beyond the eastern boundary of the MPUD).
PD&E StudyIn order to minimize wetland impacts and expedite the completion of S.R. 56 from County Road 581 east to U. S. 301, the Developer shall cause to be prepared, funded and completed a single, unified revised PD&E alignment study of S.R. 56 from Xxxxxx Chapel Lakes Boulevard west of the MPUD, east to U.S. 301 beyond the eastern boundary of the MPUD, including any studies or analysis determined by FDOT to be necessary to complete such study (collectively, the "PD&E Study"). The County acknowledges and agrees that the PD&E Study application will proceed more expeditiously if the property owners for the Xxxxxx Chapel Lakes MPUD, Zephyr Egg property and the Xxxxxx Ranch property (each anticipated to be affected by the S.R. 56 alignment and collectively, the "S.R. 56 Project Owners") agree to the relocation of S.R. 56 as contemplated by the PD&E Study application. As such, the County agrees to use its best efforts to work with the Developer and the S. R. 56 Project Owners to obtain such cooperation on or before December 31, 2005, and Developer agrees to notify the County when such efforts are necessary. In any event, the Developer agrees to commence the PD&E Study by December 31, 2005, and to complete the PD&E Study by September 30, 2006. The Developer shall be eligible to request extension for the completion of the PD&E Study, subject to approval by the County, upon Developer’s demonstration of good faith effort on the part of Developer to complete the PD&E Study and delay caused by matters beyond the Developer’s reasonable control. However, any extension beyond those allowed by Section 11.w. of this Agreement shall require an amendment of this Agreement. The Developer shall submit to the County for the County's review the proposed PD&E Study application concurrent with submitting the same to any other reviewing agencies. The County shall review and provide any comments to the PD&E Study application within thirty (30) days of receipt thereof, failing which the County shall be deemed to have agreed to its submittal by the Developer to the reviewing agencies; provided, however, the County may continue, after such thirty (30) day review period, to make comments on the PD&E Study application to the reviewing agencies. The PD&E Study, which was completed by the Developer and approved by the County, FDOT and FHA, establishes the alignment of S.R. 56 from Xxxxxx Chapel Lakes Boulevard (west of the MPUD) east to U.S. 301 (beyond the eastern boundary of the MPUD).
PD&E Study. (Class of Action)
PD&E StudyThe CONSULTANT will conduct a PD&E Study in accordance with the requirements of the FDOT’s PD&E Manual. During the PD&E Study phase, the CONSULTANT will prepare a conceptual design of the recommended alternative with the help of a public engagement and outreach program. The CONSULTANT will assess potential effects on the social, economic, natural, and physical environment to avoid, minimize, and/or mitigate impacts.

Related to PD&E Study

  • The Study 1The parties must comply with, and conduct the Study in accordance with, the Protocol and any conditions of the Reviewing HREC. In addition the parties must comply with the following, as applicable:

  • Study An application for leave of absence for professional study must be supported by a written statement indicating what study or research is to be undertaken, or, if applicable, what subjects are to be studied and at what institutions.

  • Feasibility Study A feasibility study will identify the potential costs, service quality and other benefits which would result from contracting out the work in question. The cost analysis for the feasibility study shall not include the Employer’s indirect overhead costs for existing salaries or wages and benefits for administrative staff or for rent, equipment, utilities, and materials, except to the extent that such costs are attributable solely to performing the services to be contracted out. Upon completion of the feasibility study, the Employer agrees to furnish the Union with a copy if the feasibility study, the bid from the Apparent Successful Bidder and all pertinent information upon which the Employer based its decision to contract out the work including, but not limited to, the total cost savings the Employer anticipates. The Employer shall not go forward with contracting out the work in question if more than sixty percent (60%) of any projected savings resulting from the contracting out are attributable to lower employee wage and benefit costs.

  • Development Work The Support Standards do not include development work either (i) on software not licensed from CentralSquare or (ii) development work for enhancements or features that are outside the documented functionality of the Solutions, except such work as may be specifically purchased and outlined in Exhibit 1. CentralSquare retains all Intellectual Property Rights in development work performed and Customer may request consulting and development work from CentralSquare as a separate billable service.

  • Development Program A. Development activities to be undertaken (Please break activities into subunits with the date of completion of major milestones) B. Estimated total development time

  • Development Plan document specifying the work program, schedule, and relevant investments required for the Development and the Production of a Discovery or set of Discoveries of Oil and Gas in the Concession Area, including its abandonment.

  • Clinical Studies The animal and other preclinical studies and clinical trials conducted by the Company or on behalf of the Company were, and, if still pending are, to the Company’s knowledge, being conducted in all material respects in compliance with all Applicable Laws and in accordance with experimental protocols, procedures and controls generally used by qualified experts in the preclinical study and clinical trials of new drugs and biologics as applied to comparable products to those being developed by the Company; the descriptions of the results of such preclinical studies and clinical trials contained in the Registration Statement and the Prospectus are accurate and complete in all material respects, and, except as set forth in the Registration Statement and the Prospectus, the Company has no knowledge of any other clinical trials or preclinical studies, the results of which reasonably call into question the clinical trial or preclinical study results described or referred to in the Registration Statement and the Prospectus when viewed in the context in which such results are described; and the Company has not received any written notices or correspondence from the FDA, the EMA, or any other domestic or foreign governmental agency requiring the termination, suspension or modification of any preclinical studies or clinical trials conducted by or on behalf of the Company that are described in the Registration Statement and the Prospectus or the results of which are referred to in the Registration Statement and the Prospectus.

  • Research Program The term “

  • Development Phase contractual phase initiated with the approval of ANP for the Development Plan and which is extended during the Production Phase while investments in xxxxx, equipment, and facilities for the Production of Oil and Gas according to the Best Practices of the Oil Industry are required.

  • Research Plan The Parties recognize that the Research Plan describes the collaborative research and development activities they will undertake and that interim research goals set forth in the Research Plan are good faith guidelines. Should events occur that require modification of these goals, then by mutual agreement the Parties can modify them through an amendment, according to Paragraph 13.6.